Lumify and Restasis drug interactions - a phase IV clinical study of FDA data
Summary:
Drug interactions are reported among people who take Lumify (brimonidine tartrate) and Restasis (cyclosporine). Common drug interactions include reaction to preservatives among females and drug ineffective among males.
The phase IV clinical study analyzes what interactions people have when they take Lumify and Restasis. It is created by eHealthMe based on reports of 36 people who take the same drugs from the FDA, and is updated regularly.
What is Lumify?
Lumify has active ingredients of brimonidine tartrate. eHealthMe is studying from 3,670 Lumify users. Check the latest studies of Lumify.
What is Restasis?
Restasis has active ingredients of cyclosporine. It is often used in dry eyes. eHealthMe is studying from 35,199 Restasis users. Check the latest studies of Restasis.
36 people who take Lumify and Restasis together, and have interactions are studied.
What are the common drug interactions of Lumify and Restasis, by gender? *:
female:
- Reaction to preservatives
- Foreign body sensation in eyes (feeling of something in eye)
- Back injury
- Dyspnoea (difficult or laboured respiration)
- Headache (pain in head)
- Blepharospasm (any abnormal contraction or twitch of the eyelid)
- Drug hypersensitivity
- Instillation site lacrimation
- Instillation site pain
- Acne (skin problems that cause pimples)
male:
- Drug ineffective
- Burning sensation
- Vision blurred
- Eye disorder
- Eye irritation
What are the common drug interactions of Lumify and Restasis, by age (0-1 to 60+)? *:
0-1:
n/a
2-9:
n/a
10-19:
n/a
20-29:
- Eye irritation
- Eye pain
30-39:
- Ocular hyperaemia (an abnormally large amount of blood in eye)
40-49:
n/a
50-59:
- Eye irritation
- Drug ineffective
- Headache (pain in head)
- Ocular hyperaemia (an abnormally large amount of blood in eye)
- Reaction to preservatives
- Acne (skin problems that cause pimples)
- Blister (small pocket of fluid within the upper layers of the skin caused by forceful rubbing (friction), burning, freezing, chemical exposure)
- Blood pressure increased
- Body height decreased
- Dizziness
60+:
- Eye irritation
- Drug ineffective
- Reaction to preservatives
- Asthenia (weakness)
- Asthenopia (eyestrain-tiredness of the eyes caused by prolonged close work by a person with an uncorrected vision problem)
- Corneal disorder
- Dry skin
- Eye disorder
- Fatigue (feeling of tiredness)
- Halo vision (rainbow vision)
What are the existing conditions these people have? *
- Ocular Hyperaemia (an abnormally large amount of blood in eye): 19 people, 52.78%
- Neurotrophic Keratopathy (decreased corneal sensitivity and poor corneal healing): 4 people, 11.11%
- Hypersensitivity: 2 people, 5.56%
- Eyelid Ptosis (falling of the upper or lower eyelid): 2 people, 5.56%
* Approximation only. Some reports may have incomplete information.
Do you take Lumify and Restasis?
- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, side effects of, and alternative drugs to the 2 drugs:
Browse all drug interactions of Lumify and Restasis:
a b c d e f g h i j k l m n o p q r s t u v w x y zSub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Lumify:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all side effects of Restasis:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Lumify and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Restasis and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zRelated publications that referenced our studies
- O’Brien FE, O’Connor RM, Clarke G, Donovan MD, Dinan TG, Griffin BT, Cryan JF, "The P-glycoprotein inhibitor cyclosporin A differentially influences behavioural and neurochemical responses to the antidepressant escitalopram", Behavioural brain research, 2014 Mar .
- O’Brien FE, O’Connor RM, Clarke G, Donovan MD, Dinan TG, Griffin BT, Cryan JF, "The P-glycoprotein inhibitor cyclosporin A differentially influences behavioural and neurochemical responses to the antidepressant escitalopram", Behavioural brain research, 2014 Mar .
How the study uses the data?
The study uses data from the FDA. It is based on brimonidine tartrate and cyclosporine (the active ingredients of Lumify and Restasis, respectively), and Lumify and Restasis (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Drug interactions of Arava and Xarelto - 31 seconds ago
- Could Lysodren cause Cytolytic Hepatitis? - 34 seconds ago
- Could Norco cause Fluid Retention? - 38 seconds ago
- Could Demerol cause Systemic Inflammatory Response Syndrome? - 38 seconds ago
- Could Dulera cause Gastroesophageal Reflux Disease? - 50 seconds ago
- Drug interactions of Seroquel Xr and Clopra - 56 seconds ago
- Could Levaquin cause Migraine? - a minute ago
- Could Carboplatin cause Pseudomonas Infection? - a minute ago
- Fosinipril vs. Quinapril, side effect and effectiveness comparison - a minute ago
- Could Meclizine cause Cerebral Ischaemia? - a minute ago